Linked Life Data

14504022

Source:http://linkedlifedata.com/resource/pubmed/id/14504022

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:14504022rdf:typepubmed:Citationlld:pubmed
pubmed-article:14504022lifeskim:mentionsumls-concept:C0008976lld:lifeskim
pubmed-article:14504022lifeskim:mentionsumls-concept:C0034656lld:lifeskim
pubmed-article:14504022lifeskim:mentionsumls-concept:C0025516lld:lifeskim
pubmed-article:14504022lifeskim:mentionsumls-concept:C0027358lld:lifeskim
pubmed-article:14504022lifeskim:mentionsumls-concept:C1274040lld:lifeskim
pubmed-article:14504022lifeskim:mentionsumls-concept:C0150543lld:lifeskim
pubmed-article:14504022lifeskim:mentionsumls-concept:C0376196lld:lifeskim
pubmed-article:14504022lifeskim:mentionsumls-concept:C0205195lld:lifeskim
pubmed-article:14504022lifeskim:mentionsumls-concept:C1280519lld:lifeskim
pubmed-article:14504022lifeskim:mentionsumls-concept:C0065152lld:lifeskim
pubmed-article:14504022pubmed:issue4lld:pubmed
pubmed-article:14504022pubmed:dateCreated2003-9-23lld:pubmed
pubmed-article:14504022pubmed:abstractTextThe efficacy of lofexidine/naloxone was compared with lofexidine/placebo in a double-blind, randomized, placebo-controlled trial in 89 opiate-dependent patients. There were no significant differences between the two groups in the proportion of patients completing detoxification or in the length of stay. Patients in the active naloxone group demonstrated gradual reductions in levels of withdrawal and craving over the detoxification period. At completion of detoxification, patients who received naloxone maintained a level of withdrawal consistently lower than that in the placebo group; however, naloxone did not substantially accelerate the resolution of the withdrawal syndrome. Implications for future research are discussed.lld:pubmed
pubmed-article:14504022pubmed:languageenglld:pubmed
pubmed-article:14504022pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14504022pubmed:citationSubsetIMlld:pubmed
pubmed-article:14504022pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14504022pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14504022pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14504022pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14504022pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14504022pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14504022pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14504022pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14504022pubmed:statusMEDLINElld:pubmed
pubmed-article:14504022pubmed:issn1055-0496lld:pubmed
pubmed-article:14504022pubmed:authorpubmed-author:GossopMichael...lld:pubmed
pubmed-article:14504022pubmed:authorpubmed-author:StrangJohnJlld:pubmed
pubmed-article:14504022pubmed:authorpubmed-author:BestDavidDlld:pubmed
pubmed-article:14504022pubmed:authorpubmed-author:BeswickTracyTlld:pubmed
pubmed-article:14504022pubmed:authorpubmed-author:BearnJennyJlld:pubmed
pubmed-article:14504022pubmed:authorpubmed-author:ReesSianSlld:pubmed
pubmed-article:14504022pubmed:issnTypePrintlld:pubmed
pubmed-article:14504022pubmed:volume12lld:pubmed
pubmed-article:14504022pubmed:ownerNLMlld:pubmed
pubmed-article:14504022pubmed:authorsCompleteYlld:pubmed
pubmed-article:14504022pubmed:pagination295-305lld:pubmed
pubmed-article:14504022pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:14504022pubmed:meshHeadingpubmed-meshheading:14504022...lld:pubmed
pubmed-article:14504022pubmed:meshHeadingpubmed-meshheading:14504022...lld:pubmed
pubmed-article:14504022pubmed:meshHeadingpubmed-meshheading:14504022...lld:pubmed
pubmed-article:14504022pubmed:meshHeadingpubmed-meshheading:14504022...lld:pubmed
pubmed-article:14504022pubmed:meshHeadingpubmed-meshheading:14504022...lld:pubmed
pubmed-article:14504022pubmed:meshHeadingpubmed-meshheading:14504022...lld:pubmed
pubmed-article:14504022pubmed:meshHeadingpubmed-meshheading:14504022...lld:pubmed
pubmed-article:14504022pubmed:meshHeadingpubmed-meshheading:14504022...lld:pubmed
pubmed-article:14504022pubmed:meshHeadingpubmed-meshheading:14504022...lld:pubmed
pubmed-article:14504022pubmed:meshHeadingpubmed-meshheading:14504022...lld:pubmed
pubmed-article:14504022pubmed:meshHeadingpubmed-meshheading:14504022...lld:pubmed
pubmed-article:14504022pubmed:meshHeadingpubmed-meshheading:14504022...lld:pubmed
pubmed-article:14504022pubmed:meshHeadingpubmed-meshheading:14504022...lld:pubmed
pubmed-article:14504022pubmed:meshHeadingpubmed-meshheading:14504022...lld:pubmed
pubmed-article:14504022pubmed:meshHeadingpubmed-meshheading:14504022...lld:pubmed
pubmed-article:14504022pubmed:meshHeadingpubmed-meshheading:14504022...lld:pubmed
pubmed-article:14504022pubmed:meshHeadingpubmed-meshheading:14504022...lld:pubmed
pubmed-article:14504022pubmed:meshHeadingpubmed-meshheading:14504022...lld:pubmed
pubmed-article:14504022pubmed:meshHeadingpubmed-meshheading:14504022...lld:pubmed
pubmed-article:14504022pubmed:meshHeadingpubmed-meshheading:14504022...lld:pubmed
pubmed-article:14504022pubmed:articleTitleThe effectiveness of combined naloxone/lofexidine in opiate detoxification: results from a double-blind randomized and placebo-controlled trial.lld:pubmed
pubmed-article:14504022pubmed:affiliationThe National Addiction Centre, London, UK.lld:pubmed
pubmed-article:14504022pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:14504022pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:14504022pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:14504022pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:14504022pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14504022lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14504022lld:pubmed